OreStocks

MustGrow Biologics Corp. press release

BioMedNewsBreaks - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Releases Further Lab Results Validating Natural Biopesticide Control of Banana Disease

TSXV - TSX Venture Exchange · Canada

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0), an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops, as released additional lab results confirming its mustard-derived natural biopesticide ability to obtain 100% control of on the disease Fusarium wilt TR4. A banana disease often referred to as the Panama disease, Fusarium wilt TR4 is destroying the $25 billion global banana industry. These most-recent results were conducted by a third party and validate earlier test results that confirm the efficacy of MustGrow’s safe and effective natural, plant-based biopesticide. The test results confirm 100% control achieved at economic rates as low as 5 gal/acre within a three-day testing period. The company is now preparing for upcoming field studies. "With this additional efficacy confirmation, we are very excited about the opportunity to potentially help the banana industry manage this devastating disease,” said MustGrow COO Colin Bletsky in the press release. “Reproduction of the same positive results through yet another independent laboratory has further validated our approach. With a more defined dose response, we are now ready to commence field testing with deeper refinement of our study design."

To view the full press release, visit: https://ibn.fm/hpV6D

About MustGrow Biologics Corp.

MustGrow is a publicly traded, agriculture biotech company focused on providing natural, science-based biological solutions for high-value crops, including fruits and vegetables. MustGrow has designed and owns a U.S. EPA-approved natural solution that uses the mustard seed's natural defense mechanism to protect plants from pests and diseases. Over 110 independent tests have been completed, validating MustGrow's safe and effective signature products. The product, in granule format, is EPA-approved across all key U.S. states and by Health Canada's Pest Management Regulatory Agency (“PMRA”) as a biopesticide for high-value crops, including fruits and vegetables. MustGrow has now concentrated a liquid format, TerraMG, that with regulatory approval could be applied through standard drip or spray equipment, improving functionality and performance features. In addition, this mustard-derived technology could have other applications in several different industries from pre-plant soil treatment to post harvest disease control and food preservation. For more information about the company, please visitwww.MustGrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at http://ibn.fm/MGROF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWireto reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text "STOCKS" to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW) San Francisco, California www.BioMedWire.com 415.949.5050 Office Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Earlier from MustGrow Biologics Corp.